BDBM50003326 3-[2-(2-Acetylamino-5-guanidino-pentanoylamino)-acetylamino]-N-(1-carbamoyl-2-hydroxy-ethyl)-succinamic acid::3-[4-amino(imino)methylamino-1-methylcarboxamido-(1S)-butylcarboxamidomethylcarboxamido]-3-[1-carbamoyl-2-hydroxy-(1S)-ethylcarbamoyl]propanoic acid::CHEMBL420106

SMILES CC(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(N)=O

InChI Key InChIKey=GFOJSWCCTWFSJD-DCAQKATOSA-N

Data  3 KI  3 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 6 hits for monomerid = 50003326   

TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Smithkline Beecham Pharmaceuticals Research And Development

Curated by ChEMBL
LigandPNGBDBM50003326(3-[2-(2-Acetylamino-5-guanidino-pentanoylamino)-ac...)
Affinity DataKi:  4.20E+3nMAssay Description:Inhibition of 125[I] Fibrinogen binding to isolated purified human fibrinogen receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Smithkline Beecham Pharmaceuticals Research And Development

Curated by ChEMBL
LigandPNGBDBM50003326(3-[2-(2-Acetylamino-5-guanidino-pentanoylamino)-ac...)
Affinity DataKi:  3.70E+4nMAssay Description:Inhibition of ADP-induced platelet aggregation in canine platelet-rich plasmaMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Smithkline Beecham Pharmaceuticals Research And Development

Curated by ChEMBL
LigandPNGBDBM50003326(3-[2-(2-Acetylamino-5-guanidino-pentanoylamino)-ac...)
Affinity DataKi:  6.20E+4nMAssay Description:Inhibition of canine platelet-rich plasma agregation induced by ADPMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Smithkline Beecham Pharmaceuticals Research And Development

Curated by ChEMBL
LigandPNGBDBM50003326(3-[2-(2-Acetylamino-5-guanidino-pentanoylamino)-ac...)
Affinity DataIC50:  9.13E+4nMAssay Description:Inhibition of canine platelet-rich plasma agregation induced by ADPMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Smithkline Beecham Pharmaceuticals Research And Development

Curated by ChEMBL
LigandPNGBDBM50003326(3-[2-(2-Acetylamino-5-guanidino-pentanoylamino)-ac...)
Affinity DataIC50:  9.13E+4nMAssay Description:Inhibition of ADP-induced platelet aggregation in canine platelet-rich plasmaMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Smithkline Beecham Pharmaceuticals Research And Development

Curated by ChEMBL
LigandPNGBDBM50003326(3-[2-(2-Acetylamino-5-guanidino-pentanoylamino)-ac...)
Affinity DataIC50:  6.72E+4nMAssay Description:Inhibition of canine platelet-rich plasma agregation induced by ADPMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed